Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase

BMC Neuroscience

Volumn 9, Issue SUPPL. 2, 2008, Pages

  Chai, Siew Yeen ^a   Yeatman, Holly R ^a   Parker, Michael W ^b,c   Ascher, David B ^c   Thompson, Philip E ^d   Mulvey, Hayley T ^d   Albiston, Anthony L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN II [3-8]; ANGIOTENSIN II [3-8] DERIVATIVES; ENZYME INHIBITOR; GLUCOSE TRANSPORTER 4; HEMORPHIN 7; HEMORPHIN 7 DERIVATIVES; INSULIN REGULATED AMINOPEPTIDASE; NEUROPEPTIDE; UNCLASSIFIED DRUG; ANGIOTENSIN II; ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; CYSTYL AMINOPEPTIDASE; DRUG DERIVATIVE; HEMOGLOBIN; LEUCYL CYSTINYL AMINOPEPTIDASE; LEUCYL-CYSTINYL AMINOPEPTIDASE; LVV HEMORPHIN 7; LVV-HEMORPHIN-7; NOOTROPIC AGENT; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; CATALYSIS; CELL TRANSPORT; COGNITION; COMPUTER MODEL; CONFERENCE PAPER; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; GLUCOSE TRANSPORT; MEMORY; MENTAL PERFORMANCE; NONHUMAN; PROTEIN DOMAIN; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANGIOTENSIN II; ANIMALS; COGNITION; CYSTINYL AMINOPEPTIDASE; HEMOGLOBINS; HUMANS; MEMORY; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS;

EID: 57449086119     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-S2-S14     Document Type: Conference Paper

References (54)

1. Wolfe MS Therapeutic strategies for Alzheimer's disease Nat Rev Drug Discov 2002, 1:859-866. 10.1038/nrd938 12415246
2. Birks J Cholinesterase inhibitors for Alzheimer's disease Cochrane Database Systematic Reviews 2006, CD005593.
3. Kaduszkiewicz H Zimmermann T Beck-Bornholdt H Bussche van den H Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials BMJ 2005, 331:321-327. 1183129 16081444 10.1136/bmj.331.7512.321
4. Cosman KM Boyle LL Porsteinsson AP Memantine in the treatment of mild-to-moderate Alzheimer's disease Expert Opin Pharmacother 2007, 8:203-214. 10.1517/14656566.8.2.203 17257090
5. Marshall E A star-studded search for memory-enhancing drugs Science 2004, 304:36-38. 10.1126/science.304.5667.36 15060299
6. Braszko JJ Kupryszewski G Witczuk B Wisniewski K Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats Neuroscience 1988, 27:777-783. 10.1016/0306-4522(88)90182-0 3252173
7. Wright JW Miller-Wing AV Shaffer MJ Higginson C Wright DE Hanesworth JM Harding JW Angiotensin II(3-8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory Brain Res Bull 1993, 32:497-502. 10.1016/0361-9230(93)90297-O 8221142
8. Braszko JJ Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV Peptides 2004, 25:1195-1203. 10.1016/j.peptides.2004.04.014 15245880
9. Wright JW Stubley L Pederson ES Kramar EA Hanesworth JM Harding JW Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning J Neurosci 1999, 19:3952-3961. 10234025
10. Lee J Albiston AL Allen AM Mendelsohn FAO Ping SE Barrett GL Murphy M Morris MJ McDowall SG Chai SY Effect of intracerebroventricular injection of AT4 receptor ligands, Nle1-angiotensin IV and LVv-hemorphin 7, on spatial learning in rats Neuroscience 2004, 124:341-349. 10.1016/ j.neuroscience.2003.12.006 14980384
11. Wright JW Clemens JA Panetta JA Smalstig EB Weatherly LA Kramar EA Pederson ES Mungall BH Harding JW Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats Brain Res 1996, 717:1-11. 10.1016/ 0006-8993(95)01454-3 8738247
12. Olson ML Olson EA Qualls JH Stratton JJ Harding JW Wright JW Norleucine1-angiotensin IV alleviates mecamylamine-induced spatial memory deficits Peptides 2004, 25:233-241. 10.1016/ j.peptides.2003.12.005 15063004
13. Pederson ES Harding JW Wright JW Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog Regul Pept 1998, 74:97-103. 10.1016/S0167-0115(98)00028-7 9712169
14. Pederson ES Krishnan R Harding JW Wright JW A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits Regul Pept 2001, 102:147-156. 10.1016/S0167-0115(01)00312-3 11730987
15. Albiston AL Pederson ES Burns P Purcell B Wright JW Harding JW Mendelsohn FA Weisinger RS Chai SY Reversal of scopolamine-induced memory deficits by LVV-hemorphin 7 in rats in the passive avoidance and Morris water maze paradigms Behav Brain Res 2004, 154:239-243. 15302130
16. Wisniewski K Borawska M Car H The effect of angiotensin II and its fragments on post-alcohol impairment of learning and memory Pol J Pharmacol 1993, 45:23-29. 8401756
17. Wayner MJ Armstrong DL Phelix CF Wright JW Harding JW Angiotensin IV enhances LTP in rat dentate gyrus in vivo Peptides 2001, 22:1403-1414. 10.1016/S0196-9781(01)00475-2 11514021
18. Kramar EA Armstrong DL Ikeda S Wayner MJ Harding JW Wright JW The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro Brain Res 2001, 897:114-121. 10.1016/S0006-8993(01)02100-X 11282364
19. Albiston AL McDowall SG Matsacos D Sim P Clune E Mustafa T Lee J Mendelsohn FA Simpson RJ Connolly LM Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase J Biol Chem 2001, 276:48263-48266. 10.1074/jbc.C100512200
20. Albiston AL Mustafa T McDowall SG Mendelsohn FA Lee J Chai SY AT(4) receptor is insulin-regulated membrane aminopeptidase: Potential mechanisms of memory enhancement Trends Endocrinol Metab 2003, 14:72-77. 10.1016/S1043-2760(02)00037-1 12591177
21. Lew RA Mustafa T Ye S McDowall SG Chai SY Albiston AL Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP) J Neurochem 2003, 86:344-350. 10.1046/ j.1471-4159.2003.01852.x 12871575
22. Moeller I Paxinos G Mendelsohn FA Aldred GP Casley D Chai SY Distribution of AT4 receptors in the Macaca fascicularis brain Brain Res 1996, 712:307-324. 10.1016/0006-8993(95)01482-9 8814907
23. Chai SY Bastias MA Clune EF Matsacos DJ Mustafa T Lee JH McDowall SG Mendelsohn FA Paxinos G Albiston AL Distribution of angiotensin IV binding sites (AT(4) receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography J Chem Neuroanat 2000, 20:339-348. 10.1016/S0891-0618(00)00112-5 11207430
24. Fernando R Larm J Albiston AL Chai SY Distribution and cellular localization of the insulin regulated aminopeptidase (IRAP) in the rat central nervous system J Comp Neurol 2005, 487:372-390. 10.1002/ cne.20585 15906313
25. Albiston AL Burns P Daswani D Fernando RN Yeatman HR Chai SY Characterisation of the behavioural phenotype of the IRAP knockout mouse 7th IBRO World Congress of Neuroscience; Melbourne, Australia, 12-17 July 2007 Abstract 225.
26. Keller SR Scott HM Mastick CC Aebersold R Lienhard GE Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles J Biol Chem 1995, 270:23612-23618. 10.1074/ jbc.270.35.20497 7559527
27. James DE Brown R Navarro J Pilch PF Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein Nature 1988, 333:183-185. 10.1038/333183a0 3285221
28. Waters SB D'Auria M Martin SS Nguyen C Kozma LM Luskey KL The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes J Biol Chem 1997, 272:23323-23327. 10.1074/ jbc.272.37.23323 9287343
29. Peck GR Ye S Pham V Fernando RN Macaulay SL Chai SY Albiston AL Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase Mol Endocrinol 2006, 20:2576-2583. 10.1210/me.2005-0476 16762977
30. Larance M Ramm G Stockli J van Dam EM Winata S Wasinger V Simpson F Graham M Junutula JR Guilhaus M Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking J Biol Chem 2005, 280:37803-37813. 10.1074/jbc.M503897200 16154996
31. Chi NW Lodish HF Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles J Biol Chem 2000, 275:38437-38444. 10.1074/jbc.M007635200 10988299
32. Katagiri H Asano T Yamada T Aoyama T Fukushima Y Kikuchi M Kodama T Oka Y Acyl-coenzyme A dehydrogenases are localized on GLUT4-containing Vesicles via association with insulin-regulated aminopeptidase in a manner dependent on its dileucine motif Mol Endocrinol 2002, 16:1049-1059. 10.1210/me.16.5.1049 11981039
33. Tojo H Kaieda I Hattori H Katayama N Yoshimura K Kakimoto S Fujisawa Y Presman E Brooks CC Pilch PF The Formin family protein, formin homolog overexpressed in spleen, interacts with the insulin-responsive aminopeptidase and profilin IIa Mol Endocrinol 2003, 17:1216-1229. 10.1210/me.2003-0056 12677009
34. Hosaka T Brooks CC Presman E Kim SK Zhang Z Breen M Gross DN Sztul E Pilch PF p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation Mol Biol Cell 2005, 16:2882-2890. 1142432 15800058 10.1091/mbc.E05-01-0072
35. Nanus DM Engelstein D Gastl GA Gluck L Vidal MJ Morrison M Finstad CL Bander NH Albino AP Molecular cloning of the human kidney differentiation antigen gp160: Human aminopeptidase A Proc Natl Acad Sci USA 1993, 90:7069-7073. 47077 8346219 10.1073/pnas.90.15.7069
36. Olsen J Cowell GM Konigshofer E Danielsen EM Moller J Laustsen L Hansen OC Welinder KG Engberg J Hunziker W Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA FEBS Lett 1988, 238:307-314. 10.1016/0014-5793(88)80502-7 2901990
37. Funk CD Radmark O Fu JY Matsumoto T Jornvall H Shimizu T Samuelsson B Molecular cloning and amino acid sequence of leukotriene A4 hydrolase Proc Natl Acad Sci USA 1987, 84:6677-6681. 299146 2821541 10.1073/ pnas.84.19.6677
38. Laustsen PG Vang S Kristensen T Mutational analysis of the active site of human insulin-regulated aminopeptidase Eur J Biochem 2001, 268:98-104. 10.1046/j.1432-1327.2001.01848.x 11121108
39. Rudberg PC Tholander F Thunnissen MM Haeggstrom JZ Leukotriene A4 hydrolase/aminopeptidase. Glutamate 271 is a catalytic residue with specific roles in two distinct enzyme mechanisms J Biol Chem 2002, 277:1398-1404. 10.1074/jbc.M106577200 11675384
40. Ye S Chai SY Lew RA Albiston AL Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain Biol Chem 2007, 388:399-403. 10.1515/BC.2007.044 17391061
41. Ross SA Herbst JJ Keller SR Lienhard GE Trafficking kinetics of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes Biochem Biophys Res Commun 1997, 239:247-251. 10.1006/bbrc.1997.7459 9345303
42. Rogi T Tsujimoto M Nakazato H Mizutani S Tomoda Y Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family J Biol Chem 1996, 271:56-61. 10.1074/jbc.271.1.56 8550619
43. Yamahara N Nomura S Suzuki T Itakura A Ito M Okamoto T Tsujimoto M Nakazato H Mizutani S Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy Life Sciences 2000, 66:1401-1410. 10.1016/S0024-3205(00)00451-3 11210715
44. Wallis MG Lankford MF Keller SR Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP Am J Physiol Endocrinol Metab 2007, 293:E1092-1102. 10.1152/ajpendo.00440.2007 17684103
45. Herbst JJ Ross SA Scott HM Bobin SA Morris NJ Lienhard GE Keller SR Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes Am J Physiol 1997, 272:E600-606. 9142880
46. Matsumoto H Nagasaka T Hattori A Rogi T Tsuruoka N Mizutani S Tsujimoto M Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides Eur J Biochem 2001, 268:3259-3266. 10.1046/j.1432-1327.2001.02221.x 11389728
47. Krishnan R Hanesworth JM Wright JW Harding JW Structure-binding studies of the adrenal AT4 receptor: Analysis of position two- and three-modified angiotensin IV analogs Peptides 1999, 20:915-920. 10.1016/ S0196-9781(99)00081-9 10503768
48. Lee JH Mustafa T McDowall SG Mendelsohn FAO Brennan MB Lew R Albiston AL Chai SY Structure-activity study of LVV-hemorphin-7: Angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase (IRAP) J Pharmacol Exp Ther 2003, 305:205-211. 10.1124/jpet.102.045492 12649370
49. Axen A Lindeberg G Demaegdt H Vauquelin G Karlen A Hallberg M Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands J Pept Sci 2006, 12:705-713. 10.1002/psc.782 16967438
50. Kobori T Goda K Sugimoto K Ota T Tomisawa K Amino compounds and angiotensin IV receptor agonists US Patent 1998.
51. Lukaszuk A Demaegdt H Szemenyei E Toth G Tymecka D Micicka A Vanderheyden P Vauquelin G Tourwé D β-Homo-amino acid scan of Angiotensin IV 29th European Peptide Symposium; Gdansk, Poland: 3-8 September 2006 Abstract 282.
52. Thunnissen MM Nordlund P Haeggstrom JZ Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation Nat Struct Biol 2001, 8:131-135. 10.1038/84117 11175901
53. Chai SY Parker MW Albiston AL Morton CJ Ng HL Ye S Mendelsohn FAO Enzyme inhibitors and uses thereof US Patent 2006.
54. Albiston AL Morton CJ Ng HL Pham V Yeatman HR Ye S Fernando RN De Bundel D Ascher DB Mendelsohn FAO Parker MW Chai SY Identification and characterization of a new class of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase FASEB J 2008. 18716029